ENDUREX | 60 UNITS 15MG GW501516 + 15MG MK-2866

15 mg GW501516 + 15 mg MK-2866

ENDUREX™ is a dual-pathway research formulation combining two widely studied compounds associated with metabolic regulation and endurance signaling pathways. This formulation is designed for laboratory investigation into mechanisms related to energy metabolism, mitochondrial activity, and skeletal muscle signaling.

Each capsule contains precisely measured quantities of GW501516 and MK-2866, two compounds commonly examined in preclinical and experimental models evaluating metabolic efficiency and tissue signaling pathways.

Research Compound Profile

GW501516 (Cardarine)

CAS: 317318-70-0

GW501516 is a PPAR-δ agonist investigated for its effects on lipid metabolism, mitochondrial biogenesis, and endurance-related metabolic pathways. Research suggests activation of PPAR-δ may influence fatty acid oxidation and energy utilization.

MK-2866 (Ostarine)

CAS: 1202044-20-9

MK-2866 is a selective androgen receptor modulator (SARM) examined in research models for its interaction with androgen receptors and potential effects on skeletal muscle signaling and tissue maintenance pathways.

Formula Overview

Each capsule contains:

GW501516 — 15 mg

MK-2866 — 15 mg

Bottle contains 60 capsules.

Research Applications

ENDUREX™ may be explored in laboratory settings studying:

• metabolic regulation

• endurance-associated signaling pathways

• mitochondrial energy utilization

• skeletal muscle receptor activity

• lipid oxidation pathways

Disclaimer

This product is intended for laboratory research purposes only.

Not for human consumption.

Not for use in diagnostic or therapeutic procedures.